RecruitingNCT06004115
Lorazepam or placebo during brain scans of threat responses in depression and anxiety
About this title
Read the official source — NCT06004115Medication studyAges 18–65United States
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- TulsaSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: November 8, 2023
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 165
- Sponsor
- Laureate Institute for Brain Research, Inc.
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06004115
- Official title
Show the full official title
Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and Depression
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Tulsa
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Laureate Institute for Brain Research, Inc., a research institute.
Does this study involve medication?
Yes. The study involves medication, including Lorazepam.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
